Clinical Trial Update: Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating whether Helicobacter pylori eradication affects idiopathic central serous chorioretinopathy; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Chorioretinopathy

Snippet

Sponsor: Tabriz University | Conditions: Central Serous Chorioretinopathy | Phase 1, Phase 2 | Status: COMPLETED